2/6
10:58 am
bmrn
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target lowered by analysts at Piper Sandler from $122.00 to $84.00. They now have an "overweight" rating on the stock.
Low
Report
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target lowered by analysts at Piper Sandler from $122.00 to $84.00. They now have an "overweight" rating on the stock.
2/2
09:40 am
bmrn
Jefferies Downgrades Amicus Therapeutics, Inc. (FOLD) to Buy And Lowers Price Target Amid Takeover Developments [Yahoo! Finance]
Low
Report
Jefferies Downgrades Amicus Therapeutics, Inc. (FOLD) to Buy And Lowers Price Target Amid Takeover Developments [Yahoo! Finance]
1/31
07:03 pm
bmrn
Should You Buy BioMarin Pharmaceutical Before Feb. 18? [Yahoo! Finance]
Low
Report
Should You Buy BioMarin Pharmaceutical Before Feb. 18? [Yahoo! Finance]
1/29
04:05 pm
bmrn
BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility
Low
Report
BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility
1/29
01:55 am
bmrn
BioMarin's Amicus Deal Funding Reshapes Debt Load And Rare Disease Reach [Yahoo! Finance]
Low
Report
BioMarin's Amicus Deal Funding Reshapes Debt Load And Rare Disease Reach [Yahoo! Finance]
1/28
08:03 am
bmrn
BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $80.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $80.00 price target on the stock.
1/28
07:13 am
bmrn
Upcoming Acquisition Resulting in Bullish Stance on BioMarin Pharmaceutical (BMRN) [Yahoo! Finance]
Low
Report
Upcoming Acquisition Resulting in Bullish Stance on BioMarin Pharmaceutical (BMRN) [Yahoo! Finance]
1/26
08:02 am
bmrn
BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility [Yahoo! Finance]
Medium
Report
BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility [Yahoo! Finance]
1/26
07:45 am
bmrn
BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility
Low
Report
BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility
1/20
08:02 am
bmrn
BioMarin Pharmaceutical (NASDAQ:BMRN) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $98.00 price target on the stock, up previously from $84.00.
Medium
Report
BioMarin Pharmaceutical (NASDAQ:BMRN) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $98.00 price target on the stock, up previously from $84.00.
1/16
09:53 am
bmrn
Making U.S. biotech more competitive with China's could help rare disease patients, experts say [CNBC]
Low
Report
Making U.S. biotech more competitive with China's could help rare disease patients, experts say [CNBC]
1/14
03:53 am
bmrn
Does BioMarin Pharmaceutical (BMRN) Price Weakness Contrast With Its Cash Flow Valuation? [Yahoo! Finance]
Low
Report
Does BioMarin Pharmaceutical (BMRN) Price Weakness Contrast With Its Cash Flow Valuation? [Yahoo! Finance]
1/13
07:07 pm
bmrn
BMRN or TARS: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
Low
Report
BMRN or TARS: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
1/13
06:06 am
bmrn
BioMarin Pharmaceutical touts $3.2B 2025 revenue, Voxzogo surge and Amicus deal at JPM Conference [Yahoo! Finance]
Medium
Report
BioMarin Pharmaceutical touts $3.2B 2025 revenue, Voxzogo surge and Amicus deal at JPM Conference [Yahoo! Finance]
1/12
04:39 pm
bmrn
BioMarin Appoints Arpit Davé Chief Digital and Information Officer [Yahoo! Finance]
Medium
Report
BioMarin Appoints Arpit Davé Chief Digital and Information Officer [Yahoo! Finance]
1/12
04:05 pm
bmrn
BioMarin Appoints Arpit Davé Chief Digital and Information Officer
Medium
Report
BioMarin Appoints Arpit Davé Chief Digital and Information Officer
1/9
07:03 pm
bmrn
1 of Wall Street's Favorite Stock with Exciting Potential and 2 We Find Risky [Yahoo! Finance]
Low
Report
1 of Wall Street's Favorite Stock with Exciting Potential and 2 We Find Risky [Yahoo! Finance]
1/8
04:37 pm
bmrn
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA [Yahoo! Finance]
Low
Report
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA [Yahoo! Finance]
1/8
04:05 pm
bmrn
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
Low
Report
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
1/6
12:41 pm
bmrn
Will Galafold Be Able to Aid FOLD's Top Line Heading Into Q4 Earnings? [Yahoo! Finance]
Low
Report
Will Galafold Be Able to Aid FOLD's Top Line Heading Into Q4 Earnings? [Yahoo! Finance]
1/4
07:27 pm
bmrn
How Investors Are Reacting To BioMarin (BMRN) Halting BMN349 And Refocusing Its Rare Disease Pipeline [Yahoo! Finance]
Low
Report
How Investors Are Reacting To BioMarin (BMRN) Halting BMN349 And Refocusing Its Rare Disease Pipeline [Yahoo! Finance]
1/2
01:29 pm
bmrn
When healthcare M&A hits the cold chain [Yahoo! Finance]
Low
Report
When healthcare M&A hits the cold chain [Yahoo! Finance]
1/1
06:40 am
bmrn
H.C. Wainwright: BioMarin's (BMRN) Amicus Acquisition Stabilizes Cash Flow While Voxzogo Remains Near-Term Driver [Yahoo! Finance]
Low
Report
H.C. Wainwright: BioMarin's (BMRN) Amicus Acquisition Stabilizes Cash Flow While Voxzogo Remains Near-Term Driver [Yahoo! Finance]
12/30
04:45 pm
bmrn
BioMarin Acquiring Amicus -- Both Great Companies, Only One Worth Buying Now [Seeking Alpha]
Low
Report
BioMarin Acquiring Amicus -- Both Great Companies, Only One Worth Buying Now [Seeking Alpha]
12/26
05:12 pm
bmrn
BioMarin Pharmaceuticals: Amicus Transforms Business Case Overnight [Seeking Alpha]
Low
Report
BioMarin Pharmaceuticals: Amicus Transforms Business Case Overnight [Seeking Alpha]